• chandra vamsi. s
• Anandh.k.h

– Introduction: Mucormycosis is an opportunistic fulminant fungal infection caused by zygomycetes. This fungus is more common, particularly in the uncontrolled diabetes mellitus and immunocompromised state. There has been a recent surge of mucormycosis cases during the wave of COVID 19 because of patients having a weak immune system due to the COVID 19 infection which is also being treated with steroids which puts the body in a immunocompromised state. This also causes uncontrolled diabetes which is a predisposing factor for mucormycosis, also is the reason for delayed recovery. Zygomycetes impinge into the vascular network, resulting in thrombosis and necrosis of the surrounding hard and soft tissues. The infection begins in the nose and paranasal sinuses due to inhalation of fungal spores and spread to orbital and intracranial structures either by direct invasion or through the blood vessels. Aim and Method: In this study we have retrospectively studied 30 cases of mucormycosis admitted in saveetha medical college and hospital between April 2021 to September 2021. All the cases included in this study had a recent history of COVID 19 infection in the past 2 weeks for which they were treated with steroids. Results: 30 patients were included in the study, all of them had a recent history of COVID 19 in the past 2 weeks for which they received steroids as a part of their treatment for COVID19. This study involved 19(63.3%) males and 11(36.6%) females. The first symptoms is hemifacial pain in 12(40%) patients, toothache in 4(13.3%) patients, peri orbital pain in 6(20%) patients, nasal discharge in 8(26.6%) patients. Conclusion: Murcormycosis is a life-threatening disease which requires immediate management and extensive care. Knowing the presenting symptoms and clinical features of the disease helps in early diagnosis which helps in better and multidirectional approach for the management of mucormycosis

Mucormycosis, COVID 19

"A study on the presentation of symptoms in mucormycosis patients post COVID 19 infection – A retrospective study ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 5, page no.i78-i83, May-2023, Available :http://www.jetir.org/papers/JETIR2305841.pdf

"A study on the presentation of symptoms in mucormycosis patients post COVID 19 infection – A retrospective study ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 5, page no. ppi78-i83, May-2023, Available at : http://www.jetir.org/papers/JETIR2305841.pdf